Divergent prescribing paradigms in cardiovascular care: a comparative analysis of government and private healthcare settings in Goa, India [0.03%]
印度果阿政府和私人医疗保健机构心血管护理中的分歧处方范式：比较分析
Gianine Megan Lobo,Felicia Mascarenhas,Aditi Vasudev Parab et al.
Gianine Megan Lobo et al.
Background: Cardiovascular diseases (CVDs) are the leading cause of mortality globally and a growing burden in India. This study aimed to assess prescribing patterns for CVDs across government and private healthcare secto...
Response to: "finasteride prescribed for hair loss consistently leads to depression" [0.03%]
对“治疗脱发的非那雄胺致抑郁”的回复
Minh-Ha Nguyen,Tien H Tran,Jeffrey Donovan
Minh-Ha Nguyen
A plain language summary: an overview of objective (scientific) data and patient experiences showing how effective lemborexant is for treating insomnia [0.03%]
简明摘要：客观（科学）数据和患者体验的概览，说明莱莫尔塞抗失眠的有效性
Charles M Morin,Alex Desautels,Dinesh Kumar et al.
Charles M Morin et al.
Ponatinib in CML and Ph+ ALL: balancing high efficacy with vascular safety [0.03%]
ponatinib治疗慢性髓性白血病和Ph+急性淋巴细胞白血病：在高效与血管安全之间取得平衡
Arihant Senthil,Aarushi Gupta,Vasu Bansal et al.
Arihant Senthil et al.
Chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) are driven by the BCR:ABL1 fusion and remain highly responsive to tyrosine kinase inhibitors (TKIs). Ponatinib, a third-generation TK...
Managing patients with cardiovascular-kidney-metabolic syndrome: a guideline-driven practical guide for primary care physicians [0.03%]
心血管-肾脏-代谢综合征患者的管理：全科医生的循证实践指南解读
Steve Fordan,Imran Afridi,Andrew Garza et al.
Steve Fordan et al.
Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic disorder characterized by an overall reduction in cardiovascular health that occurs as a result of the development of ≥2 cardiovascular, kidney, or metabolic risk factors. Preval...
CV risk: if you aren't testing ACR, you aren't seeing the full picture [0.03%]
CV风险：如果不检测ACR，您将无法获得完整信息
Ana Cebrián,David C Wheeler,Nikolaus Marx et al.
Ana Cebrián et al.
Chronic kidney disease (CKD) remains a hidden epidemic, under-recognized and under-diagnosed, despite widespread recognition of the benefits of systematic screening of at-risk individuals and early diagnosis. CKD is an important driver of c...
Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database [0.03%]
抗肿瘤坏死因子诱导的血管炎：来自法国国家药物警戒数据库的数据解析
Facundo Izquierdo,Greta Gourier,Caroline Clabecq et al.
Facundo Izquierdo et al.
Objectives: The increasing use of tumor necrosis factor (TNF) inhibitors poses new challenges in terms of drug iatrogenicity and diagnosis. In this study, we focus on the description of the TNF-inhibitors-induced vasculit...
Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures [0.03%]
急诊癫痫发作患者血清nesfatin-1水平与体质指数和C反应蛋白的关系
Timur Sarac,Yesim Isler,Halil Kaya et al.
Timur Sarac et al.
Introduction: Reliable biomarkers reflecting acute seizure activity in patients presenting to the emergency department remain insufficiently defined. This study aimed to compare serum nesfatin-1 levels in patients present...
Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing [0.03%]
肾功能不全或接受透析模式患者的硫酸多粘菌素酯和多粘菌素药代动力学的系统性评价及其精确给药意义
Asha K Rajan,Maria Ioana Onofrei,Ananya Rudra et al.
Asha K Rajan et al.
Background: Optimizing colistin dosing in patients with renal impairment, particularly those undergoing renal replacement therapy (RRT), remains a major challenge due to complex and variable pharmacokinetics. This systema...